Agile regulations for advanced therapeutic products and clinical trials

From Health Canada

Current status: Closed

This consultation ran from July 18, 2019 to September 30, 2019.

The goal of this consultation was to seek feedback on what Health Canada should consider in developing new clinical trials regulations as well as implementing the pathway for Advanced Therapeutic Products. The department aimed to continue the conversation with stakeholders and gathered other ideas to help ensure our approach supports innovation while protecting the health and safety of Canadians.

Join in: how to participate

Send us an email:

Send an email to hc.hpfb.engagement-mobilisation.dgpsa.sc@canada.ca to request the consultation information document and questions by email.

Who was the focus of this consultation

Health Canada engaged with:

Key questions for discussion

Please send an email to hc.hpfb.engagement-mobilisation.dgpsa.sc@canada.ca to request the consultation information document and questions by email.

Related information

Contact us

Email: hc.hpfb.engagement-mobilisation.dgpsa.sc@canada.ca

Page details

Date modified: